Condition
Ganglioneuroblastoma, Nodular clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ganglioneuroblastoma, Nodular clinical trials that are recruiting, at sites in 5 countries (most in Canada (2), Puerto Rico (2), United States (2)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Combining dinutuximab with chemotherapy and surgery for treating high-risk neuroblastoma in children
This study is testing if adding a new medicine called dinutuximab to regular chemotherapy and surgery can help children with high-risk neuroblastoma live longer without their cancer coming back.
-
Adding iobenguane I-131 or lorlatinib to intensive treatment for children and young adults with high-risk neuroblastoma
This trial tests whether adding the radioactive drug iobenguane I-131 or the targeted drug lorlatinib to standard intensive therapy helps children and young adults with newly diagnosed high-risk neuroblastoma or nodular ganglioneuroblastoma stay free of disease longer.
Related topics
Quick answers
How many Ganglioneuroblastoma, Nodular clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Canada (2 trials), Puerto Rico (2 trials), United States (2 trials), Australia (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.